|
|||||
|
Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter |
Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
BCRX | Thackray Helen M. | Chief R&D Officer | Apr 03 | Sale | 8.29 | 7,000 | 58,030 | 207,275 | Apr 05 04:33 PM |
BCRX | Thackray Helen M. | Chief R&D Officer | Dec 15 | Sale | 10.89 | 3,125 | 34,031 | 133,275 | Dec 19 04:58 PM |
BCRX | Thackray Helen M. | Chief R&D Officer | Apr 01 | Sale | 16.20 | 7,600 | 123,120 | 136,400 | Apr 04 04:32 PM |
GLYC | Thackray Helen M. | SVP Clinical Development, CMO | Dec 08 | Sale | 15.01 | 2,000 | 30,020 | 148,615 | Dec 12 04:14 PM |
GLYC | Thackray Helen M. | SVP Clinical Development, CMO | Sep 18 | Sale | 13.00 | 2,000 | 26,000 | 150,615 | Sep 18 06:15 PM |
GLYC | Thackray Helen M. | SVP Clinical Development, CMO | May 25 | Sale | 15.57 | 2,000 | 31,140 | 152,615 | May 30 04:07 PM |
GLYC | Thackray Helen M. | SVP Clinical Development, CMO | May 19 | Sale | 12.14 | 2,000 | 24,280 | 154,615 | May 22 09:23 PM |
GLYC | Thackray Helen M. | VP Clinical Development, CMO | Oct 03 | Sale | 7.00 | 4,000 | 28,001 | 156,615 | Oct 04 04:22 PM |
GLYC | Thackray Helen M. | VP Clinical Development, CMO | Jul 20 | Sale | 8.00 | 2,000 | 16,000 | 160,615 | Jul 21 05:27 PM |
GLYC | Thackray Helen M. | VP Clinical Development, CMO | Jul 01 | Sale | 7.40 | 5,068 | 37,503 | 179,547 | Jul 06 05:07 PM |
GLYC | Thackray Helen M. | VP Clinical Development, CMO | Jul 05 | Sale | 7.01 | 10,136 | 71,053 | 169,411 | Jul 06 05:07 PM |
GLYC | Thackray Helen M. | VP Clinical Development, CMO | Jul 06 | Sale | 6.68 | 6,796 | 45,397 | 162,615 | Jul 06 05:07 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite